Home » NEWS » Health » Cypress Pharmaceutical rolls out new generic drug

Cypress Pharmaceutical rolls out new generic drug

MADISON — Cypress Pharmaceutical Inc. has commercially launched Epinastine HCl Ophthalmic Solution, 0.05%, which is AT-rated to Allergan’s ELESTAT (epinastine HCl ophthalmic solution) 0.05%.

As the first company to file an abbreviated new drug application (ANDA) containing a paragraph IV certification for this product, Cypress has been awarded a 180-day period of marketing exclusivity.

Cypress, founded in 1993, is a specialty pharmaceutical company that develops, markets and distributes generic prescription pharmaceutical products to leading national pharmaceutical wholesalers, chain drug stores, distributors and other retail merchandisers.

Source: Cypress Pharmaceutical Inc.

About For the MBJ

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>